US Patent Issued to MEDICON PHARMACEUTICALS on May 13 for "Treating pain associated with chemotherapy-induced peripheral neuropathy" (New York Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,964, issued on May 13, was assigned to MEDICON PHARMACEUTICALS INC. (Setauket, N.Y.).

"Treating pain associated with chemotherapy-induced peripheral neuropathy" was invented by Basil Rigas (Setauket, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features methods of preventing and/or treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy (CIPN)."

The patent was filed on Nov. 21, 2023, under Application No. 18/515,734.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.htm...